Comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 vs 46 Xx Gonadal Dysgenesis C0685837
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Isolated 17 20 Lyase Deficiency and 46 XX Gonadal Dysgenesis for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
A rare condition involving deficiency of the 17,20-lyase enzyme needed for androgen synthesis. Affects 46,XY individuals and causes undervirilization. Managed with hormone therapy.
46 Xx Gonadal Dysgenesis C0685837
A condition affecting ovarian development in individuals with two X chromosomes. May impact puberty and fertility. Treatment typically includes hormone replacement and supportive care.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
0-0
46 Xx Gonadal Dysgenesis C0685837
12-16
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
severe
46 Xx Gonadal Dysgenesis C0685837
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
Chronic
46 Xx Gonadal Dysgenesis C0685837
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
No
46 Xx Gonadal Dysgenesis C0685837
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
reproductive
46 Xx Gonadal Dysgenesis C0685837
reproductive
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
endocrine
46 Xx Gonadal Dysgenesis C0685837
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-isolated-17-20-lyase-deficiency-C5681470 and 46-xx-gonadal-dysgenesis-C0685837 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 46 Xx Gonadal Dysgenesis C0685837 | Discriminating power |
|---|---|---|---|
| Genital development | Undervirilization may be evident from birth; exact phenotype varies. | Typical female external genitalia are often described; not definitive. | Moderate |
| Pubertal development | Androgen deficiency may impair virilization; timing is not fixed by these data. | Puberty and fertility may be affected, often recognized around ages 12–16. | Moderate |
| Chromosomal sex | Occurs in individuals with a 46,XY karyotype. | Occurs in individuals with a 46,XX karyotype. | High |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 when
46,XY infant with atypical genital development
Isolated 17,20-lyase deficiency is an endocrine cause of undervirilization.
Moderate
Suspected androgen-synthesis defect
The supplied mechanism is deficient conversion needed for androgen production.
High
Early-life presentation
Source onset is recorded as birth rather than adolescence.
Moderate
Choose 46 Xx Gonadal Dysgenesis C0685837 when
46,XX adolescent with delayed puberty
Gonadal dysgenesis may affect ovarian function and pubertal progression.
Moderate
Primary concern is ovarian development
The condition is described as a genetic disorder of ovarian development.
High
Fertility counseling is needed
Fertility may be affected, but individual potential is not established here.
Low
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 46 Xx Gonadal Dysgenesis C0685837 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY supports the left concept. | 46,XX supports the right concept. | Karyotype distinguishes chromosomal context but does not alone prove either diagnosis. |
| Steroid pathway evaluation | Pattern may suggest impaired androgen synthesis; no cutoff is supplied. | Not primarily defined by isolated 17,20-lyase deficiency. | Abnormal results need specialist correlation and are not diagnostic by themselves. |
| Gonadal assessment | Assessment addresses undervirilization and gonadal status. | Assessment addresses impaired ovarian development. | Imaging or histology, when indicated, should be interpreted by specialists. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
- Outcome
- Chronic condition; long-term outcome is not quantified here.
- Factors
- Severity is listed as severe; androgen deficiency and response to care may matter.
46 Xx Gonadal Dysgenesis C0685837
- Outcome
- Chronic condition with potentially moderate impact; outcome is not quantified.
- Factors
- Pubertal development, ovarian function, and fertility concerns may influence course.
Time frame: From recognition through adolescence and adulthood; exact timelines are not established.
Karyotype, hormone findings, gonadal status, and access to specialist care require interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Sex-hormone deficiency | Androgen deficiency may require hormone therapy. Ovarian insufficiency may require hormone replacement. Specific agents and doses are not established by this source. |
| Fertility impairment | Fertility effects are plausible but not quantified here. Fertility may be affected. Individual reproductive potential requires specialist evaluation. |
| Psychosocial impact | Atypical development and chronic care may cause distress. Delayed puberty and fertility concerns may cause distress. Support needs vary and are not predictable from these data. |
Patient education highlights
- HighDiagnosis versus test result
A karyotype or hormone result is not itself a complete diagnosis and needs clinical interpretation.
- HighHormone care
Hormone therapy or replacement may be used, but treatment must be individualized.
- MediumLong-term follow-up
Both conditions are described as chronic and may need endocrine and reproductive follow-up.